These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7677241)

  • 1. Antihistamine effects on actual driving performance in a standard test: a summary of Dutch experience, 1989-94.
    O'Hanlon JF; Ramaekers JG
    Allergy; 1995 Mar; 50(3):234-42. PubMed ID: 7677241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simulated car-driving study on the effects of acute administration of levocetirizine, fexofenadine, and diphenhydramine in healthy Japanese volunteers.
    Inami A; Matsuda R; Grobosch T; Komamura H; Takeda K; Yamada Y; Miyake M; Hiraoka K; Maurer M; Yanai K; Tashiro M
    Hum Psychopharmacol; 2016 May; 31(3):167-77. PubMed ID: 26999510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
    Grant JA; Riethuisen JM; Moulaert B; DeVos C
    Ann Allergy Asthma Immunol; 2002 Feb; 88(2):190-7. PubMed ID: 11868924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Driving ability after acute and sub-chronic administration of levocetirizine and diphenhydramine: a randomized, double-blind, placebo-controlled trial.
    Verster JC; de Weert AM; Bijtjes SI; Aarab M; van Oosterwijck AW; Eijken EJ; Verbaten MN; Volkerts ER
    Psychopharmacology (Berl); 2003 Aug; 169(1):84-90. PubMed ID: 12721777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiotoxicity of new antihistamines and cisapride.
    Paakkari I
    Toxicol Lett; 2002 Feb; 127(1-3):279-84. PubMed ID: 12052668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations among non-sedating antihistamines: are there real differences?
    Mattila MJ; Paakkari I
    Eur J Clin Pharmacol; 1999 Apr; 55(2):85-93. PubMed ID: 10335901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antihistaminics. Side effects also after raising dosage at the placebo level].
    MMW Fortschr Med; 2003 May; 145(22):50-1. PubMed ID: 12866280
    [No Abstract]   [Full Text] [Related]  

  • 8. Antihistamines and driving ability: evidence from on-the-road driving studies during normal traffic.
    Verster JC; Volkerts ER
    Ann Allergy Asthma Immunol; 2004 Mar; 92(3):294-303; quiz 303-5, 355. PubMed ID: 15049392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acrivastine, terfenadine and diphenhydramine effects on driving performance as a function of dose and time after dosing.
    Ramaekers JG; O'Hanlon JF
    Eur J Clin Pharmacol; 1994; 47(3):261-6. PubMed ID: 7867679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risks of non-sedating antihistamines.
    Lindquist M; Edwards IR
    Lancet; 1997 May; 349(9061):1322. PubMed ID: 9142080
    [No Abstract]   [Full Text] [Related]  

  • 11. Newer antihistamines.
    Med Lett Drugs Ther; 2001 Apr; 43(1103):35. PubMed ID: 11331439
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects.
    Hey JA; del Prado M; Sherwood J; Kreutner W; Egan RW
    Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of mizolastine and clemastine on actual driving and psychomotor performance in healthy volunteers.
    Vuurman EF; Uiterwijk MM; Rosenzweig P; O'Hanlon JF
    Eur J Clin Pharmacol; 1994; 47(3):253-9. PubMed ID: 7867678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central nervous system effects of H1-receptor antagonists in the elderly.
    Simons FE; Fraser TG; Maher J; Pillay N; Simons KJ
    Ann Allergy Asthma Immunol; 1999 Feb; 82(2):157-60. PubMed ID: 10071518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of emedastine and cetirizine, alone and with alcohol, on actual driving of males and females.
    Vermeeren A; Ramaekers JG; O'Hanlon JF
    J Psychopharmacol; 2002 Mar; 16(1):57-64. PubMed ID: 11949773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of nonsedative antihistamines. II. Assessment of its antihistaminic potency.
    Aparicio S; Granel C; Randazzo L; Valencia M; Olivé Pérez A
    Allergol Immunopathol (Madr); 1992; 20(5):207-10. PubMed ID: 1363340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and subchronic effects of the H1-histamine receptor antagonist ebastine in 10, 20 and 30 mg dose, and triprolidine 10 mg on car driving performance.
    Brookhuis KA; De Vries G; De Waard D
    Br J Clin Pharmacol; 1993 Jul; 36(1):67-70. PubMed ID: 8104017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of ventricular arrhythmias associated with nonsedating antihistamine drugs.
    de Abajo FJ; Rodríguez LA
    Br J Clin Pharmacol; 1999 Mar; 47(3):307-13. PubMed ID: 10215756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urticaria due to antihistamines.
    Sánchez Morillas L; Rojas Pérez-Ezquerra P; Reaño Martos M; Sanz ML; Laguna Martínez JJ
    J Investig Allergol Clin Immunol; 2011; 21(1):66-8. PubMed ID: 21370726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of supratherapeutic doses of ebastine and terfenadine on the QT interval.
    Gillen MS; Miller B; Chaikin P; Morganroth J
    Br J Clin Pharmacol; 2001 Aug; 52(2):201-4. PubMed ID: 11488779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.